179 related articles for article (PubMed ID: 9497468)
1. Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2.
Minihan M; Goggin M; Cleary PE
Br J Ophthalmol; 1997 Dec; 81(12):1073-9. PubMed ID: 9497468
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of full-thickness macular holes using autologous serum.
Wells JA; Gregor ZJ
Eye (Lond); 1996; 10 ( Pt 5)():593-9. PubMed ID: 8977788
[TBL] [Abstract][Full Text] [Related]
3. Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery.
Schaub F; Gözlügöl N; von Goscinski C; Enders P; Heindl LM; Dahlke C
Eur J Ophthalmol; 2021 Mar; 31(2):664-672. PubMed ID: 32019342
[TBL] [Abstract][Full Text] [Related]
4. The results of vitreous surgery for chronic macular holes.
Thompson JT; Sjaarda RN; Lansing MB
Retina; 1997; 17(6):493-501. PubMed ID: 9428011
[TBL] [Abstract][Full Text] [Related]
5. Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study.
Korobelnik JF; Hannouche D; Belayachi N; Branger M; Guez JE; Hoang-Xuan T
Ophthalmology; 1996 Apr; 103(4):590-4. PubMed ID: 8618757
[TBL] [Abstract][Full Text] [Related]
6. CLOSING MACULAR HOLES WITH "MACULAR PLUG" WITHOUT GAS TAMPONADE AND POSTOPERATIVE POSTURING.
Chakrabarti M; Benjamin P; Chakrabarti K; Chakrabarti A
Retina; 2017 Mar; 37(3):451-459. PubMed ID: 27491044
[TBL] [Abstract][Full Text] [Related]
7. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes.
Thompson JT; Glaser BM; Sjaarda RN; Murphy RP
Am J Ophthalmol; 1995 Jan; 119(1):48-54. PubMed ID: 7825689
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2.
Thompson JT; Glaser BM; Sjaarda RN; Murphy RP; Hanham A
Ophthalmology; 1994 Jul; 101(7):1195-200. PubMed ID: 8035983
[TBL] [Abstract][Full Text] [Related]
9. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes.
Lansing MB; Glaser BM; Liss H; Hanham A; Thompson JT; Sjaarda RN; Gordon AJ
Ophthalmology; 1993 Jun; 100(6):868-71; discussion 871-2. PubMed ID: 8510899
[TBL] [Abstract][Full Text] [Related]
10. Short-Acting Gas Tamponade with Strict Face-Down Posturing for the Treatment of Idiopathic Macular Hole.
Gotzaridis S; Liazos E; Petrou P; Georgalas I
Semin Ophthalmol; 2017; 32(5):597-601. PubMed ID: 27367053
[TBL] [Abstract][Full Text] [Related]
11. [A preliminary observation on vitrectomy combined with autologous platelet concentrate for the treatment of idiopathic macular holes].
Zhao M; Li X; Lü Y; Li C
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):260-3, 16. PubMed ID: 11877202
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange.
Blumenkranz MS; Ohana E; Shaikh S; Chang S; Coll G; Morse LS; De Bustros S
Ophthalmic Surg Lasers; 2001; 32(3):198-207. PubMed ID: 11371086
[TBL] [Abstract][Full Text] [Related]
13. Surgery for idiopathic full-thickness macular holes.
Gregor ZJ
Eye (Lond); 1996; 10 ( Pt 6)():685-90. PubMed ID: 9091363
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery.
Kim SS; Smiddy WE; Feuer WJ; Shi W
Retina; 2008; 28(10):1408-15. PubMed ID: 18827734
[TBL] [Abstract][Full Text] [Related]
15. Silicone oil vs. gas for the treatment of full-thickness macular hole.
Pertile G; Claes C
Bull Soc Belge Ophtalmol; 1999; 274():31-6. PubMed ID: 10670160
[TBL] [Abstract][Full Text] [Related]
16. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery.
Thompson JT; Smiddy WE; Williams GA; Sjaarda RN; Flynn HW; Margherio RR; Abrams GW
Ophthalmology; 1998 Apr; 105(4):700-6. PubMed ID: 9544645
[TBL] [Abstract][Full Text] [Related]
17. Visual and anatomical success with short-term macular tamponade and autologous platelet concentrate.
Mulhern MG; Cullinane A; Cleary PE
Graefes Arch Clin Exp Ophthalmol; 2000 Jul; 238(7):577-83. PubMed ID: 10955659
[TBL] [Abstract][Full Text] [Related]
18. SULFURHEXAFLUORIDE (SF6) VERSUS PERFLUOROPROPANE (C3F8) GAS AS TAMPONADE IN MACULAR HOLE SURGERY.
Modi A; Giridhar A; Gopalakrishnan M
Retina; 2017 Feb; 37(2):283-290. PubMed ID: 28118283
[TBL] [Abstract][Full Text] [Related]
19. To posture or not to posture after macular hole surgery.
Dhawahir-Scala FE; Maino A; Saha K; Mokashi AA; McLauchlan R; Charles S
Retina; 2008 Jan; 28(1):60-5. PubMed ID: 18185139
[TBL] [Abstract][Full Text] [Related]
20. Outcome of 2 cc pure sulfur hexafluoride gas tamponade for macular hole surgery.
Kannan NB; Adenuga OO; Kumar K; Ramasamy K
BMC Ophthalmol; 2016 Jun; 16():73. PubMed ID: 27255461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
